Morningstar Ratings as of 9/30/2023. Ratings are based on risk adjusted total returns, are determined monthly and are subject to change.
Rankings based on total return excluding sales charges, independently calculated and not combined to create an overall ranking. Equity Dividend Fund rated against 1,138 Large Value Funds; Large Cap Focus Growth rated against 1,125 Large Growth Funds; Health Sciences Opportunities Fund rated against 157 Health Funds; Technology Opportunities rated against 229 Technology Funds; International rated against 679 Foreign Large Blend Funds; Emerging Markets Fund rated against 718 Diversified Emerging Markets Funds; International Dividend rated against 679 Foreign Large Blend Funds. High Equity Income rated against 82 Derivative Income Funds. Mid-Cap Value rated against 379 Mid-Cap Value Funds. Mid-Cap Growth rated against 520 Mid-Cap Growth Funds. Advantage International rated against 679 Foreign Large Blend Funds. Sustainable Advantage Large Cap Core rated against 1,286 US Large Blend funds. Advantage Small Cap Core rated against 595 US Small Blend funds.
As of 9/30/2023, the Equity Dividend Fund received a Morningstar Rating of 3 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 1,138, 1,084 and 821 Large Value Funds, respectively. The Mid-Cap Growth Equity Fund received a Morningstar Rating of 2 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 520, 491 and 390 Mid-Cap Growth Funds, respectively. Performance results represent past performance and are no guarantee of future results. The Large Cap Focus Growth Fund received a Morningstar Rating of 2 stars for the 3-year period, 3 stars for the 5-year period and 3 stars for the 10-year period, rated against 1,125, 1,040 and 810 Large Growth Funds, respectively. The Health Sciences Opportunities Fund received a Morningstar Rating of 4 stars for the 3-year period, 4 stars for the 5-year period and 5 stars for the 10-year period, rated against 157, 132 and 111 Health Funds, respectively. The Technology Opportunities Fund received a Morningstar Rating of 3 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 229, 203 and 158 Technology Funds, respectively. The Emerging Markets Fund received a Morningstar Rating of 3 stars for the 3-year period, 4 stars for the 5-year period and 4 stars for the 10-year period, rated against 718, 652 and 391 Diversified Emerging Mkts Funds, respectively. The High Equity Income Fund received a Morningstar Rating of 5 stars for the 3-year period, 3 stars for the 5-year period and 4 stars for the 10-year period, rated against 82, 74 and 31 Options-based Funds, respectively. The International Fund received a Morningstar Rating of 1 stars for the 3-year period, 2 stars for the 5-year period and 2 stars for the 10-year period, rated against 679, 622 and 409 Foreign Large Blend Funds, respectively. Mid-Cap Value Fund received a Morningstar Rating of 4 stars for the 3-year period, 4 stars for the 5-year period and 4 stars for the 10-year period, rated against 379, 364 and 270 Mid-Cap Value Funds, respectively. The International Dividend received a Morningstar Rating of 3 stars for the 3-year period, 5 stars for the 5-year period and 3 stars for the 10-year period, rated against 679, 622 and 409 US Foreign Large Blend Funds, respectively. The Advantage International received a Morningstar Rating of 4 stars for the 3-year period, 4 stars for the 5-year period and 5 stars for the 10-year period, rated against 679, 622 and 409 US Foreign Large Blend Funds, respectively. The Sustainable Large Cap Core Fund received a Morningstar Rating of 3 stars for the 3-year period and 3 stars for the 5-year period, rated against 1,286 and 1,184 Large Blend Funds, respectively. The Advantage Small Cap Core Fund received a Morningstar Rating of 1 star for the 3-year period, 3 for the 5-year period, and 4 for the 10-year period, rated against 595, 556, and 386 US Small Blend Funds, respectively.
Performance data represents past performance and does not guarantee future results. Investment return and principal value will fluctuate with market conditions and may be lower or higher when you sell your shares. Current performance may differ from the performance shown. For most recent month-end performance and standardized performance, click on the fund names above.
Rankings based on total return excluding sales charges. Mid-Cap Growth Equity: 1 Year 148/558; 3 Year 373/520; 5 Year 266/491; 10 Year 36/390. Large Cap Focus Growth: 1 Year 127/1,216; 3 Year 785/1,125; 5 Year 486/1,040; 10 Year 173/810. Equity Dividend: 1 Year 553/1,221; 3 Year 596/1,138; 5 Year 452/1,084; 10 Year 198/821. Mid-Cap Value: 1 Year 167/398; 3 Year 82/379; 5 Year 47/364; 10 Year 64/270. Health Sciences Opportunities: 1 Year 37/173; 3 Year 52/157; 5 Year 27/132; 10 Year 4/111. Technology Opportunities: 1 Year 168/274; 3 Year 165/229; 5 Year 80/203; 10 Year 47/158. Emerging Markets: 1 Year 502/817; 3 Year 313/718; 5 Year 147/652; 10 Year 76/391. International Fund: 1 Year 62/730; 3 Year 586/679; 5 Year 147/622; 10 Year 196/409. High Equity Income: 1 Year 59/89; 3 Year 7/82; 5 Year 33/74; 10 Year 6/31. International Dividend: 1 Year 413/730; 3 Year 275/679; 5 Year 42/622; 10 Year 232/409. Advantage International: 1 Year 64/730; 3 Year 69/679; 5 Year 146/622; 10 Year 31/409. Sustainable Advantage Large Cap Core: 1 Year 656/1,423; 3 Year 448/1,286; 5 Year 304/1,184. Advantage Small Cap Core: 1 Year 456/613, 3 Year 510/595, 5 Year 306/556, 10 Year 88/386.
Ratings based on risk-adjusted total return, determined monthly and subject to change.
The Morningstar Rating for funds, or "star rating," is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.
